In a groundbreaking revelation, US-based Nigerian medical luminary, Dr. Christopher Ayo Otiko, has unveiled Tetracyte, a revolutionary drug heralded as the world’s most potent solution for diabetic ulcers.
This game-changing medication, endorsed by the US Drugs Agency, boasts a remarkable tenfold acceleration in the healing process compared to existing treatments.
Dr. Otiko, the visionary Chief Executive Officer of ViaDerma Inc, and a distinguished Podiatric Specialist with nearly two decades of experience, is on a mission to transform diabetic wound care.
His commitment to pioneering medical technology led to the creation of Vitastem, an unparalleled topical antibiotic that has gained global recognition.
Hailing from Akure, Ondo State, Dr. Otiko’s expertise extends to the prevention and treatment of diabetic wounds, earning him board certification in this critical field.
His impactful career journey encompasses treating life-threatening burns and establishing healthcare enterprises dedicated to specialty products.
Vitastem’s extraordinary efficacy, validated by the US Food and Drugs Agency, has averted dire consequences such as amputations, a prevalent threat in diabetes cases.
Dr. Otiko’s unwavering dedication to relieving patients’ pain and restoring their lives has propelled him to the forefront of diabetes treatment innovation.
Currently in Nigeria, Dr. Otiko has garnered interest from government agencies seeking collaboration.
His transformative approach to diabetic care promises hope and healing on an unprecedented scale.
